News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • OECD forecasts BOJ short-term policy rate will reach 2% by late 2027, lifting market expectations of tighter Japanese monetary policy.
  • BOJ policy meeting scheduled for June 15-16 now faces higher market rate expectations.
  • Nvidia CEO Jensen Huang will join President Trump's May 14-15 China delegation, signaling US tech-business engagement amid AI export controls.
  • Ascentage Pharma will present 17 clinical updates at the European Hematology Association congress, highlighting progress in CML and CLL drug candidates.
  • Swatch Group's stock has reversed from 2025 lows with bullish technicals, implying a pragmatic mid-term long trade opportunity.

Latest Articles

Motorsport Games to Report First Quarter 2026 Financial Results

Motorsport Games to Report First Quarter 2026 Financial Results

Motorsport Games Inc., a developer and publisher of official motorsport racing video games and esports ecosystems, will report its Q1 2026 financial results on May 13, 2026, followed by a management conference call and webcast. The company continues to develop and maintain leading racing simulation platforms and esports events linked to prominent m…

Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Longeveron Inc. announced that a recent Type C meeting with the FDA resulted in constructive dialogue regarding the ongoing ELPIS II Phase 2b clinical trial of laromestrocel for Hypoplastic Left Heart Syndrome (HLHS). The FDA questioned the current primary endpoint of right ventricle ejection fraction as insufficient for demonstrating efficacy and …

TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc.

TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc.

TOMI Environmental Solutions, a leader in disinfection technology, reported a 5% year-over-year revenue increase for Q1 2026, driven by strong equipment and customized system sales. The company announced a non-binding letter of intent to merge with Carbonium Core, a U.S. nuclear-grade graphite producer valued at $120 million. This merger aims to di…

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026

Nyxoah SA invites its shareholders to attend the annual and extraordinary shareholders' meetings on June 10, 2026. The agenda includes approval of 2025 financial statements, discharge of directors and auditor, reappointment of board members, approval of remuneration report, ratification of bond instrument clauses related to convertible bonds, and r…

Sanmina Corp CEO Jure Sola Executes $27.1 Million Stock Sale

Sanmina Corp CEO Jure Sola Executes $27.1 Million Stock Sale

Jure Sola, who serves as both the Chairman and Chief Executive Officer of Sanmina Corp (NASDAQ: SANM), has completed a significant sale of common stock. On May 6, 2026, Sola disposed of 118,368 shares in a direct transaction. The total value realized from this sale was approximately $27.1 million. This move comes at a time when the company's stock …

Consumers Sue Nike Over Failure to Return Tariff-Related Price Hikes

Consumers Sue Nike Over Failure to Return Tariff-Related Price Hikes

A proposed class action filed on May 8 accuses Nike of not refunding customers for price increases tied to tariffs that were later invalidated by the U.S. Supreme Court. Plaintiffs say Nike passed tariff costs to shoppers and has received or stands to receive government refunds, creating a potential double recovery unless the court intervenes.

Chemed Corp Director Executes Stock Sale Amid Strong Quarterly Performance

Chemed Corp Director Executes Stock Sale Amid Strong Quarterly Performance

A recent regulatory filing has revealed that Patrick P. Grace, a director at Chemed Corporation (NYSE: CHE), has engaged in a sale of the company's common stock. This transaction occurs against a backdrop of strong financial results for the company, which recently surpassed market expectations for its first-quarter 2026 performance.The sale by Mr. …